JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

Strona główna・Stock List・Ascendis Pharma A-S ADR

Ascendis Pharma A-S ADR

Closed

SectorHealthcare

224.81 0.76

Buy Sell

Overview

Share price change

24h

Current

Min

220.26

Max

225.94

Key metrics
By Trading Economics
Income	-22M -61M
Sales	56M 214M
Profit margin	-28.549
Employees	1,017
EBITDA	-56M -53M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+23.72% upside

Dividends
By Dow Jones
Next Earnings	11 lut 2026

Market Stats
By TradingEconomics
Market Cap	2.4B 14B
Previous open	224.05
Previous close	224.81

News Sentiment

By Acuity

54%

46%

277 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

157.66 / 167.29 Support & Resistance

Ascendis Pharma A-S ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 sty 2026, 22:31 UTC

Earnings

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29 sty 2026, 22:05 UTC

Earnings

Stryker Logs Higher 4Q Profit On Sales Gains

29 sty 2026, 21:54 UTC

Earnings

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29 sty 2026, 21:36 UTC

Earnings

Visa 1Q Sales Climb on Strong Holiday Shopping

29 sty 2026, 23:57 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29 sty 2026, 23:56 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29 sty 2026, 23:53 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29 sty 2026, 23:51 UTC

Earnings

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29 sty 2026, 23:49 UTC

Market Talk

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29 sty 2026, 23:49 UTC

Market Talk

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29 sty 2026, 23:47 UTC

Market Talk

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29 sty 2026, 23:35 UTC

Earnings

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29 sty 2026, 23:32 UTC

Market Talk

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29 sty 2026, 23:32 UTC

Market Talk

Global Equities Roundup: Market Talk

29 sty 2026, 23:15 UTC

Market Talk

Earnings

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29 sty 2026, 22:27 UTC

Earnings

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 sty 2026, 22:27 UTC

Earnings

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29 sty 2026, 22:12 UTC

Earnings

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 sty 2026, 21:55 UTC

Earnings

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Financial Services Roundup: Market Talk

29 sty 2026, 21:50 UTC

Earnings

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Health Care Roundup: Market Talk

29 sty 2026, 21:50 UTC

Market Talk

Earnings

Auto & Transport Roundup: Market Talk

29 sty 2026, 21:49 UTC

Earnings

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29 sty 2026, 21:46 UTC

Earnings

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29 sty 2026, 21:36 UTC

Earnings

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29 sty 2026, 21:32 UTC

Earnings

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 sty 2026, 21:32 UTC

Earnings

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 sty 2026, 21:30 UTC

Earnings

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29 sty 2026, 21:30 UTC

Earnings

Apple 1Q Mac Rev $8.39B >AAPL

Peer Comparison

Price change

Ascendis Pharma A-S ADR Forecast

Price Target

By TipRanks

23.72% upside

12 Months Forecast

Average 277.08 USD 23.72%

High 342 USD

Low 240 USD

Based on 13 Wall Street analysts offering 12 month price targets forAscendis Pharma A-S ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

Buy

Hold

Sell

Based on 13 analysts giving stock ratings to Ascendis Pharma A-S ADR - Dist in the past 3 months.

Technical Score

By Trading Central

157.66 / 167.29Support & Resistance

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

277 / 352 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Ascendis Pharma A-S ADR

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.